Sonal Muzumdar is a Dermatology physician affiliated with University of Connecticut. OpenAlex indexes 50 publications with 609 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
399 Farmington Ave Ste 260
Farmington, CT 060321979
Telephone
860-676-7000Provider last certified this registry record 25 Jun 2025.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Arcutis Biotherapeutics, Inc.Program year20253 payments
- ABBVIE INC.Program year20256 payments
- Incyte CorporationProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
47.7%Corticosteroid34.1%Triamcinolone Acetonide100%Part D≥14 patientsInterleukin-4 Receptor alpha Antagonist13.6%Dupixent Syringe100%Part D<11 patientsSensory organs
23.9%Corticosteroid23.9%Clobetasol Propionate100%Part D≥11 patientsCancer & immunology
14.8%Interleukin-17A Antagonist14.8%Cosentyx Sensoready (2 Pens)100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Updates in adjuvant and neoadjuvant therapies for resectable cutaneous melanoma
Journal of the American Academy of Dermatology
2025 - 64102 Cutaneous P. lilacinum Infection in an Immunocompetent Patient Successfully Treated with Terbinafine
Journal of the American Academy of Dermatology
2025 - Disability and the dermatology patient—part 1: Improving access to dermatologic care
Journal of the American Academy of Dermatology
2024 - Disability and the dermatology patient- part 2: Supporting patients with disabilities
Journal of the American Academy of Dermatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Lazar Greenfield, MD, PhD
University of Connecticut
Marlene Schwartz, MD
University of Connecticut
Andrew Winokur, MD
University of Connecticut
Leslie Wolfson, MD
University of Connecticut
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”